Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06441201 · ClinicalTrials.gov registry record
Acute Gastrointestinal Bleeding Peripheral Pulse Volume Changes
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 13
- Enrollment target
NCT06441201: Completed study, sponsored by Mayo Clinic.
NCT06441201 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 13 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06441201 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 13 participants
- Enrollment target
Study Summary
The purpose and aim of this study are to compare changes in pulse volume to non-invasively predict active bleeding or high-risk stigmata in patients undergoing a gastrointestinal endoscopy to assess feasibility of the flow meter clinically.
Primary Outcome
Peripheral pulse volume as measured by pulse flowmeter (uL/cm) pre and post endoscopic evaluation
Interventions
- DIAGNOSTIC_TEST Pulse flowmeter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2024-06-13 |
| Est. Completion | 2025-09-22 |
What the finished NCT06441201 record still lists
NCT06441201 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 13 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Pulse flowmeter is the first listed.
NCT06441201 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06441201 about?
NCT06441201 is a clinical study titled "Acute Gastrointestinal Bleeding Peripheral Pulse Volume Changes". The purpose and aim of this study are to compare changes in pulse volume to non-invasively predict active bleeding or high-risk stigmata in patients undergoing a gastrointestinal endoscopy to assess feasibility of the flow meter clinically.
What is the current status of trial NCT06441201?
This trial is currently completed. The enrollment target is 13 participants. The study started on 2024-06-13. Estimated completion is 2025-09-22.
What interventions are being tested in trial NCT06441201?
The interventions under investigation include: Pulse flowmeter (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06441201?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI